American Capital Management Doubles Down on Novanta Stock, According to Latest SEC Filing
The Motley Fool
by newsfeedback@fool.com (Jake Lerch)February 20, 2026
AI-Generated Deep Dive Summary
American Capital Management (ACM) has significantly boosted its investment in Novanta Inc., a leading provider of advanced photonics and precision motion components for medical and industrial original equipment manufacturers (OEMs). According to an SEC filing dated February 17, 2026, ACM purchased 163,005 shares of Novanta during the fourth quarter at an estimated cost of $18.56 million based on quarterly average pricing. This purchase increased ACM’s stake in Novanta by 163,005 shares, bringing its total holdings to 381,866 shares valued at $45.44 million as of the end of the quarter. The value of ACM’s NOVT position rose by $23.52 million compared to the prior quarter, reflecting both additional share purchases and appreciation in the stock price.
Novanta specializes in developing high-performance components and subsystems for critical applications across industries such as medical technology, semiconductor manufacturing, and industrial automation. Its photonics and precision motion technologies are integral to advanced equipment used in these sectors, making it a key player in enabling innovation and efficiency. ACM’s investment indicates confidence in Novanta’s growth potential and its ability to capitalize on opportunities in the medical and industrial markets.
This move by ACM is significant for several reasons. First, it underscores the growing interest in companies that supply critical components to high-tech industries, which are increasingly seen as drivers of future innovation and economic growth. Second, it highlights the belief among institutional investors like ACM that Novanta’s leadership position in photonics and precision motion gives it a competitive edge in meeting the demands of its global OEM customers. This strategic investment also aligns with broader trends in the financial markets, where demand for technology-driven solutions is on the rise.
For readers interested in finance and investing, this news provides insight into how institutional investors are positioning themselves to benefit from emerging trends in technology and industrial manufacturing. Novanta’s focus on advanced components for medical and industrial applications positions it as a key player in sectors with high growth potential. ACM’s decision to double
Verticals
financeinvesting
Originally published on The Motley Fool on 2/20/2026